Greenstone announces generic Cardura

PEAPACK, N.J. — Greenstone, a U.S.-based subsidiary of Pfizer, announced the introduction of doxazosin mesylate tablets.

The product is an authorized generic version of Cardura (doxazosin mesylate) and will be offered in 1-mg, 2-mg, 4-mg and 8-mg dosage strengths.